TY - JOUR
T1 - Intrinsic atopic dermatitis shows similar TH2 and higher T H17 immune activation compared with extrinsic atopic dermatitis
AU - Suárez-Fariñas, Mayte
AU - Dhingra, Nikhil
AU - Gittler, Julia
AU - Shemer, Avner
AU - Cardinale, Irma
AU - De Guzman Strong, Cristina
AU - Krueger, James G.
AU - Guttman-Yassky, Emma
N1 - Funding Information:
J.G.K., M.S.-F., and N.D. were supported by grant no. 5UL1RR024143-02 from the National Center for Research Resources (NCRR) , a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. E.G.-Y. was supported by the Dermatology Foundation Physician Scientist Career Development Award .
Funding Information:
Disclosure of potential conflict of interest: C. de Guzman Strong has received payment for lectures from Rockefeller University Seminar. J. G. Krueger has received grants from Rockefeller University , Amgen , Centocor , Lilly , Merck , and Pfizer and has consultant arrangements with Centocor, Lilly, and Pfizer. E. Guttman-Yassky has consultant arrangements with Leo Pharma, Celgene, Stiefel, Bristol Meyers Squibb, GlaxoSmithKline, Regeneron, Jannsen, and Merck and has received payment for lectures from Celgene and Merck. The rest of the authors declare that they have no relevant conflicts of interest.
PY - 2013/8
Y1 - 2013/8
N2 - Background: Atopic dermatitis (AD) is classified as extrinsic and intrinsic, representing approximately 80% and 20% of patients with the disease, respectively. Although sharing a similar clinical phenotype, only extrinsic AD is characterized by high serum IgE levels. Because most patients with AD exhibit high IgE levels, an "allergic"/IgE-mediated disease pathogenesis was hypothesized. However, current models associate AD with T-cell activation, particularly TH2/TH22 polarization, and epidermal barrier defects. Objective: We sought to define whether both variants share a common pathogenesis. Methods: We stratified 51 patients with severe AD into extrinsic AD (n = 42) and intrinsic AD (n = 9) groups (with similar mean disease activity/SCORAD scores) and analyzed the molecular and cellular skin pathology of lesional and nonlesional intrinsic AD and extrinsic AD by using gene expression (real-time PCR) and immunohistochemistry. Results: A significant correlation between IgE levels and SCORAD scores (r = 0.76, P < 10 -5) was found only in patients with extrinsic AD. Marked infiltrates of T cells and dendritic cells and corresponding epidermal alterations (keratin 16, Mki67, and S100A7/A8/A9) defined lesional skin of patients with both variants. However, higher activation of all inflammatory axes (including T H2) was detected in patients with intrinsic AD, particularly T H17 and TH22 cytokines. Positive correlations between TH17-related molecules and SCORAD scores were only found in patients with intrinsic AD, whereas only patients with extrinsic AD showed positive correlations between SCORAD scores and TH2 cytokine (IL-4 and IL-5) levels and negative correlations with differentiation products (loricrin and periplakin). Conclusions: Although differences in TH17 and T H22 activation exist between patients with intrinsic AD and those with extrinsic AD, we identified common disease-defining features of T-cell activation, production of polarized cytokines, and keratinocyte responses to immune products. Our data indicate that a TH2 bias is not the sole cause of high IgE levels in patients with extrinsic AD, with important implications for similar therapeutic interventions.
AB - Background: Atopic dermatitis (AD) is classified as extrinsic and intrinsic, representing approximately 80% and 20% of patients with the disease, respectively. Although sharing a similar clinical phenotype, only extrinsic AD is characterized by high serum IgE levels. Because most patients with AD exhibit high IgE levels, an "allergic"/IgE-mediated disease pathogenesis was hypothesized. However, current models associate AD with T-cell activation, particularly TH2/TH22 polarization, and epidermal barrier defects. Objective: We sought to define whether both variants share a common pathogenesis. Methods: We stratified 51 patients with severe AD into extrinsic AD (n = 42) and intrinsic AD (n = 9) groups (with similar mean disease activity/SCORAD scores) and analyzed the molecular and cellular skin pathology of lesional and nonlesional intrinsic AD and extrinsic AD by using gene expression (real-time PCR) and immunohistochemistry. Results: A significant correlation between IgE levels and SCORAD scores (r = 0.76, P < 10 -5) was found only in patients with extrinsic AD. Marked infiltrates of T cells and dendritic cells and corresponding epidermal alterations (keratin 16, Mki67, and S100A7/A8/A9) defined lesional skin of patients with both variants. However, higher activation of all inflammatory axes (including T H2) was detected in patients with intrinsic AD, particularly T H17 and TH22 cytokines. Positive correlations between TH17-related molecules and SCORAD scores were only found in patients with intrinsic AD, whereas only patients with extrinsic AD showed positive correlations between SCORAD scores and TH2 cytokine (IL-4 and IL-5) levels and negative correlations with differentiation products (loricrin and periplakin). Conclusions: Although differences in TH17 and T H22 activation exist between patients with intrinsic AD and those with extrinsic AD, we identified common disease-defining features of T-cell activation, production of polarized cytokines, and keratinocyte responses to immune products. Our data indicate that a TH2 bias is not the sole cause of high IgE levels in patients with extrinsic AD, with important implications for similar therapeutic interventions.
KW - Atopic dermatitis
KW - IgE
KW - S100 proteins
KW - T cell
KW - eczema
KW - extrinsic
KW - human skin
KW - intrinsic
KW - keratinocytes
UR - http://www.scopus.com/inward/record.url?scp=84881156451&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2013.04.046
DO - 10.1016/j.jaci.2013.04.046
M3 - Article
C2 - 23777851
AN - SCOPUS:84881156451
SN - 0091-6749
VL - 132
SP - 361
EP - 370
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -